Europe approves new injectable HIV prevention

bfmtv.com (French)

The European Commission has approved a new twice-yearly injectable HIV prevention treatment from Gilead. The treatment, named Yeytuo in Europe, offers a simplified administration compared to daily pills, potentially improving prevention for at-risk populations. The US approved it in June. Clinical trials showed over 99.9% risk reduction for HIV transmission. Concerns exist regarding its high annual cost, over $28,000 in the US.


With a significance score of 4.8, this news ranks in the top 2.3% of today's 33237 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: